- Home
- ELVN vs FIGS Comparison
ELVN vs FIGS Comparison
Compare ELVN & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | FIGS |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ELVN | FIGS |
|---|---|---|
| Price | $27.41 | $14.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $41.00 | $13.42 |
| AVG Volume (30 Days) | 647.0K | ★ 4.7M |
| Earning Date | 06-05-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.17 | ★ 850.00 |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $419,591,000.00 |
| Revenue This Year | N/A | $9.96 |
| Revenue Next Year | $40.06 | $10.12 |
| P/E Ratio | ★ N/A | $78.16 |
| Revenue Growth | N/A | ★ 59.47 |
| 52 Week Low | $13.30 | $3.57 |
| 52 Week High | $30.98 | $17.48 |
Technical Indicators
Market Signals| Indicator | ELVN | FIGS |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 58.40 |
| Support Level | $18.89 | $10.76 |
| Resistance Level | $29.63 | $17.48 |
| Average True Range (ATR) | 1.61 | 0.94 |
| MACD | -0.34 | -0.07 |
| Stochastic Oscillator | 2.18 | 65.59 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About FIGS FIGS Inc.
FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.